New Delhi. Amid growing concern over Omicron, the new form of Coronavirus, the head of the COVID Task Force, VK Paul on Tuesday said that India should have such a vaccine platform that will keep pace with the changing nature of the virus. Quickly adaptable”.
Addressing an event organized by industry body CII, Paul said that he expects the COVID-19 pandemic in India to be endemic, with low and moderate levels of infection continuing.
In the context of emerging pandemics, our platforms have to be resilient and quick to be able to respond to new types of requirements of vaccines: Dr VK Paul, Member-Health, NITI Aayog, at CII Partnership Summit
(File photo) pic.twitter.com/Y8m5tHCUWd
– ANI (@ANI) December 14, 2021
He said, “There is a possible scenario that our vaccines may be ineffective in the emerging circumstances. In the last three weeks between Omicron’s revelations, we’ve seen how many suspicions have emerged, some of which may be genuine, yet we still don’t have the final picture in front of us.”
read also
NITI Aayog member Paul said, “Therefore, it is essential for us to ensure that we have a rapidly adaptable vaccine platform. We have to prepare ourselves for a situation where we can improve the vaccine according to the changing situation. This cannot be done every three months, however, it may be possible to do it every year.” (agency)